India to Canada: Escitalopram Export Trade Route

The India to Canada Escitalopram corridor is one of India's established pharmaceutical export routes, with 344 shipments documented worth a combined $7.7M USD. The route is dominated by APOTEX RESEARCH PRIVATE LIMITED, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's escitalopram manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $22.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with escitalopram's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 13.6%, placing it at rank #5 among India's top escitalopram export destinations globally.

On the import side, key buyers of Indian escitalopram in Canada include AURO PHARMA INC,, APOTEX INC, APOTEX INC, and 24 others. AURO PHARMA INC, is the single largest importer with 17 shipments valued at $1.1M USD.

India's escitalopram exports to Canada are driven primarily by a handful of large-scale manufacturers. APOTEX RESEARCH PRIVATE LIMITED with 66 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — APOTEX RESEARCH PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED, AUROBINDO PHARMA LTD — together account for 59% of total trade value on this route. The average shipment value of $22.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as apo-escitalopram fct 10mg 100 btl 51667/ and apo-escitalopram fct 20mg 100 btl 51668/ , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AURO PHARMA INC, is the largest importer with 17 shipments worth $1.1M USD — representing 14% of all escitalopram imports from India on this route. A total of 27 buyers are active on this corridor.